Therapeutic effect of kakkonto in a mouse model of food allergy with gastrointestinal symptoms

International Archives of Allergy and Immunology

Volumn 148, Issue 3, 2009, Pages 175-185

  Yamamoto, Takeshi ^a   Fujiwara, Kanae ^a   Yoshida, Minako ^a   Kageyama Yahara, Natsuko ^a   Kuramoto, Hirofumi ^b   Shibahara, Naotoshi ^a   Kadowaki, Makoto ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

Cytokines; Diarrhea; Food allergy; Herbal medicine; Intestinal mucosal immunity; Kakkonto; Mucosal mast cells

Indexed keywords

GAMMA INTERFERON; HERBACEOUS AGENT; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 5; KAKKONTO; MESSENGER RNA; MYELOPEROXIDASE; OVALBUMIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCENDING COLON; BAGG ALBINO MOUSE; CELL COUNT; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; ENZYME ACTIVITY; FOOD ALLERGY; GASTROINTESTINAL SYMPTOM; HERBAL MEDICINE; INTESTINE MUCOSA; MALE; MAST CELL; MOUSE; MUCOSA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL; THERAPY EFFECT; TRANSCRIPTOMICS; UNINDEXED SEQUENCE; UPREGULATION;

ANAPHYLAXIS; ANIMALS; CELL MOVEMENT; CHEMOKINES; CHYMASES; COLON; DIARRHEA; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; FOOD HYPERSENSITIVITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; IMMUNOGLOBULIN E; INTERLEUKINS; INTESTINAL MUCOSA; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; OVALBUMIN; PEROXIDASE; PHYTOTHERAPY; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 53449099042     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000161578     Document Type: Article

References (45)

1. Sicherer SH, Sampson HA: 9. Food allergy. J Allergy Clin Immunol 2006;117:S470-S475.
2. Helm RM, Ermel RW, Frick OL: Nonmurine animal models of food allergy. Environ Health Perspect 2003;111:239-244.
3. McClain S, Bannon GA: Animal models of food allergy: opportunities and barriers. Curr Allergy Asthma Rep 2006;6:141-144.
4. Li XM, Schofield BH, Huang CK, Kleiner GI, Sampson HA: A murine model of IgE-mediated cow's milk hypersensitivity. J Allergy Clin Immunol 1999;103:206-214.
5. Scott RB, Maric M: Mediation of anaphylaxis-induced jejunal circular smooth muscle contraction in rats. Dig Dis Sci 1993;38:396-402.
6. Yu LC, Perdue MH: Role of mast cells in intestinal mucosal function: studies in models of hypersensitivity and stress. Immunol Rev 2001;179:61-73.
7. Mourad FH, O'Donnell LJ, Ogutu E, Dias JA, Farthing MJ: Role of 5-hydroxytryptamine in intestinal water and electrolyte movement during gut anaphylaxis. Gut 1995;36:553-557.
8. Kweon MN, Yamamoto M, Kajiki M, Takahashi I, Kiyono H: Systemically derived large intestinal CD4(+) Th2 cells play a central role in STAT6-mediated allergic diarrhea. J Clin Invest 2000;106:199-206.
9. Yamamoto T, Kuramoto H, Kadowaki M: Downregulation in aquaporin 4 and aquaporin 8 expression of the colon associated with the induction of allergic diarrhea in a mouse model of food allergy. Life Sci 2007;81:115-120.
10. Foster PS, Martinez-Moczygemba M, Huston DP, Corry DB: Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease. Pharmacol Ther 2002;94:253-264.
11. Tlaskalova-Hogenova H, Tuckova L, Lodinova-Zadnikova R, Stepankova R, Cukrowska B, Funda DP, Striz I, Kozakova H, Trebichavsky I, Sokol D, Rehakova Z, Sinkora J, Fundova P, Horakova D, Jelinkova L, Sanchez D: Mucosal immunity: its role in defense and allergy. Int Arch Allergy Immunol 2002;128:77-89.
12. Macdonald TT, Monteleone G: Immunity, inflammation, and allergy in the gut. Science 2005;307:1920-1925.
13. Sampson HA: Food allergy: when mucosal immunity goes wrong. J Allergy Clin Immunol 2005;115:139-141.
14. Bischoff S, Crowe SE: Gastrointestinal food allergy: new insights into pathophysiology and clinical perspectives. Gastroenterology 2005;128:1089-1113.
15. Bailey M, Haverson K, Inman C, Harris C, Jones P, Corfield G, Miller B, Stokes C: The development of the mucosal immune system pre- and post-weaning: balancing regulatory and effector function. Proc Nutr Soc 2005;64:451-457.
16. Bischoff S, Crowe SE: Food allergy and the gastrointestinal tract. Curr Opin Gastroenterol 2004;20:156-161.
17. Galli SJ, Nakae S, Tsai M: Mast cells in the development of adaptive immune responses. Nat Immunol 2005;6:135-142.
18. Bischoff SC, Kramer S: Human mast cells, bacteria, and intestinal immunity. Immunol Rev 2007;217:329-337.
19. Borchers AT, Sakai S, Henderson GL, Harkey MR, Keen CL, Stern JS, Terasawa K, Gershwin ME: Shosaiko-to and other Kampo (Japanese herbal) medicines: a review of their immunomodulatory activities. J Ethnopharmacol 2000;73:1-13.
20. Comar KM, Kirby DF: Herbal remedies in gastroenterology. J Clin Gastroenterol 2005;39:457-468.
21. Langmead L, Rampton DS: Review article: herbal treatment in gastrointestinal and liver disease - benefits and dangers. Aliment Pharmacol Ther 2001;15:1239-1252.
22. Saiki I: A Kampo medicine 'Juzen-taihoto' - prevention of malignant progression and metastasis of tumor cells and the mechanism of action. Biol Pharm Bull 2000;23:677-688.
23. Tatsumi T, Yamada T, Nagai H, Terasawa K, Tani T, Nunome S, Saiki I: A Kampo formulation: Byakko-ka-ninjin-to (bai-hu-jia-rensheng-tang) inhibits IgE-mediated triphasic skin reaction in mice: the role of its constituents in expression of the efficacy. Biol Pharm Bull 2001;24:284-290.
24. Nagai T, Arai Y, Emori M, Nunome SY, Yabe T, Takeda T, Yamada H: Anti-allergic activity of a Kampo (Japanese herbal) medicine 'Sho-seiryu-to (xiao-qing-long-tang)' on airway inflammation in a mouse model. Int Immunopharmacol 2004;4:1353-1365.
25. Kurokawa M, Tsurita M, Brown J, Fukuda Y, Shiraki K: Effect of interleukin-12 level augmented by Kakkon-to, a herbal medicine, on the early stage of influenza infection in mice. Antiviral Res 2002;56:183-188.
26. Yafune A, Cyong JC: Population pharmacokinetic analysis of ephedrine in Kampo prescriptions: a study in healthy volunteers and clinical use of the pharmacokinetic results. Int J Clin Pharmacol Res 2001;21:95-102.
27. Brandt EB, Strait RT, Hershko D, Wang Q, Muntel EE, Scribner TA, Zimmermann N, Finkelman FD, Rothenberg ME: Mast cells are required for experimental oral allergen-induced diarrhea. J Clin Invest 2003;112:1666-1677.
28. Ishii M, Hashimoto S, Tsutsumi S, Wada Y, Matsushima K, Kodama T, Aburatani H: Direct comparison of GeneChip and SAGE on the quantitative accuracy in transcript profiling analysis. Genomics 2000;68:136-143.
29. H2-mediated allergic responses. Nat Med 2003;9:1047-1054.
30. Utsunomiya N, Yamamoto T, Kodama T, Kuramoto H, Kadowaki M: Pathophysiological role of the cholinergic anti-inflammatory and immune pathway in a murine model of food allergy. Gastroenterology 2006;130:A-557.
31. Li XM, Zhang TF, Huang CK, Srivastava K, Teper AA, Zhang L, Schofield BH, Sampson HA: Food allergy herbal formula-1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model. J Allergy Clin Immunol 2001;108:639-646.
32. Ekelund E, Saaf A, Tengvall-Linder M, Melen E, Link J, Barker J, Reynolds NJ, Meggitt SJ, Kere J, Wahlgren CF, Pershagen G, Wickman M, Nordenskjold M, Kockum I, Bradley M: Elevated expression and genetic association links the SOCS3 gene to atopic dermatitis. Am J Hum Genet 2006;78:1060-1065.
33. Schreiber S, Rosenstiel P, Hampe J, Nikolaus S, Groessner B, Schottelius A, Kuhbacher T, Hamling J, Folsch UR, Seegert D: Activation of signal transducer and activator of transcription (STAT) 1 in human chronic inflammatory bowel disease. Gut 2002;51:379-385.
34. Wang L, Walia B, Evans J, Gewirtz AT, Merlin D, Sitaraman SV: IL-6 induces NF-kappa B activation in the intestinal epithelia. J Immunol 2003;171:3194-3201.
35. Mitsuyama K, Matsumoto S, Rose-John S, Suzuki A, Hara T, Tomiyasu N, Handa K, Tsuruta O, Funabashi H, Scheller J, Toyonaga A, Sata M: STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice. Gut 2006;55:1263-1269.
36. Hino A, Kweon MN, Fujihashi K, McGhee JR, Kiyono H: Pathological role of large intestinal IL-12p40 for the induction of Th2-type allergic diarrhea. Am J Pathol 2004;164:1327-1335.
37. Hino A, Fukuyama S, Kataoka K, Kweon MN, Fujihashi K, Kiyono H: Nasal IL-12p70 DNA prevents and treats intestinal allergic diarrhea. J Immunol 2005;174:7423-7432.
38. Castells M: Mast cell mediators in allergic inflammation and mastocytosis. Immunol Allergy Clin North Am 2006;26:465-485.
39. Guilarte M, Santos J, de Torres I, Alonso C, Vicario M, Ramos L, Martinez C, Casellas F, Saperas E, Malagelada JR: Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 2007;56:203-209.
40. Vaali K, Puumalainen TJ, Lehto M, Wolff H, Rita H, Alenius H, Palosuo T: Murine model of food allergy after epicutaneous sensitization: role of mucosal mast cell protease-1. Scand J Gastroenterol 2006;41:1405-1413.
41. Sakamoto Y, Hiromatsu K, Ishiwata K, Inagaki-Ohara K, Ikeda T, Nakamura-Uchiyama F, Nawa Y: Chronic intestinal nematode infection induces Stat6-independent interleukin-5 production and causes eosinophilic inflammatory responses in mice. Immunology 2004;112:615-623.
42. Sasaki Y, Yoshimoto T, Maruyama H, Tegoshi T, Ohta N, Arizono N, Nakanishi K: IL-18 with IL-2 protects against Strongyloides venezuelensis infection by activating mucosal mast cell-dependent type 2 innate immunity. J Exp Med 2005;202:607-616.
43. Miller HR, Pemberton AD: Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 2002;105:375-390.
44. Fukao T, Yamada T, Tanabe M, Terauchi Y, Ota T, Takayama T, Asano T, Takeuchi T, Kadowaki T, Hata Ji J, Koyasu S: Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice. Nat Immunol 2002;3:295-304.
45. Kodama T, Yamamoto T, Utsunomiya N, Kuramoto H, Kadowaki M: Pathological role of mucosal mast cells in a mouse model of food allergy: new insights from phosphatidylinositol-3 kinase deficient. Gastroenterology 2006;130:A-233.